American Society for Microbiology, Microbiology Spectrum, 2(9), 2021
DOI: 10.1128/spectrum.01138-21
Full text: Unavailable
To diagnose fungal coinfections in patients with COVID-19 in the intensive care unit, it is necessary to implement the correct treatment and to prevent them if possible. For COVID-19-associated pulmonary aspergillosis (CAPA), respiratory specimens remain the best approach since serum biomarkers are rarely positive.